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Abstract We report the p35 and p60 forms of XRCC4 protein,
appearing in human leukemia MOLT-4 or U937 cells following
X-irradiation or hyperthermia. p35 appeared in conjunction with
the cleavage of DNA-dependent protein kinase catalytic subunit
(DNA-PKcs) and the fragmentation of internucleosomal DNA,
and was suppressed by Ac-DEVD-CHO. p35 was also produced
in vitro by treating MOLT-4 cell lysate with recombinant
caspases, suggesting that p35 was a caspase-cleaved fragment of
XRCC4 in apoptotic cell death. p60 was sensitive to treatment
with phosphatase or wortmannin and was undetectable in M059J
cells deficient in DNA-PKcs. However, p60 was found in ataxia-
telangiectasia cells after irradiation. These results indicated p60
as a phosphorylated form of XRCC4, requiring DNA-PKcs but
not ataxia-telangiectasia mutated (ATM). ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Ionizing radiation (IR) causes various damage to DNA
molecules such as base alterations and single- or double-
strand breaks (DSBs), resulting in cell death, mutagenesis
and transformation. DSBs are repaired by various mecha-
nisms, including non-homologous end-joining and homolo-
gous recombination. IR-sensitive rodent cells are categorized
into several complementation groups, termed IR groups [1].
IR groups 4, 5, 6 and 7 are defective in the rejoining of
radiation-induced DSBs and also defective in V(D)J recombi-
nation [1^3]. The genes defective in IR groups 4 to 7 are
termed XRCC4 to 7 and their products are considered to be
critical factors in the non-homologous end-joining of DSBs.
XRCC5, 6 and 7 encode the subunits of DNA-dependent
protein kinase (DNA-PK), i.e. Ku86, Ku70 and DNA-PKcs
(DNA-PK catalytic subunit), respectively [1,2]. DNA-PK is
activated by binding to the ends of double-stranded DNA
and can phosphorylate in vitro a number of proteins, includ-
ing p53 and replication protein A [1,2]. DNA-PKcs is struc-
turally related to ATM (ataxia-telangiectasia mutated) and
ATR (ATM and Rad-3-related), which were recently shown
to phosphorylate p53 in vitro and, most likely, in vivo follow-
ing IR or UV irradiation [4^7]. The activities of DNA-PK,
ATM and, to a lesser extent, ATR are sensitive to phospha-
tidylinositol 3-kinase (PI-3K) inhibitor wortmannin, probably
because the catalytic domains of these kinases have sequence
similarity to PI-3K [4,5,8^10].
XRCC4 is considered a DNA ligase IV-associated protein,
as was demonstrated by immunoprecipitation studies [11^14].
Recombinant XRCC4 protein in vitro stimulates DNA bind-
ing and the ligation activity of DNA ligase IV [12,15].
XRCC4 may possibly stabilize DNA ligase IV protein in
vivo, since DNA ligase IV protein is decreased in XRCC4-
de¢cient cells [16]. Additionally, XRCC4 protein in vitro ex-
hibits DNA binding activity, preferring nicked or linear DNA
[15]. XRCC4 probably forms homodimers or oligomers and
might promote ligation by holding DSBs together [15,17,18].
Leber et al. reported that XRCC4 in vitro enhanced the
association of Ku proteins to DNA ends and to DNA-PKcs
[18]. Several groups reported that recombinant XRCC4 pro-
tein was phosphorylated by DNA-PK in vitro [11,15,18].
Modesti et al. also showed that phosphorylation of XRCC4
by DNA-PK did not a¡ect its association with DNA ligase IV
but decreased the DNA binding activity [15]. However, Miz-
uta et al. reported that the predicted phosphorylation site, i.e.
Ser53, in XRCC4 protein was not essential in V(D)J recombi-
nation [17]. Additionally, Leber et al. and Modesti et al. re-
ported that truncated XRCC4 proteins, which were not phos-
phorylated by DNA-PK in vitro, could still restore normal
radiosensitivity or V(D)J recombination of XRCC4-de¢cient
cells [15,18]. Thus, the role of the XRCC4 phosphorylation in
DSB repair and in V(D)J recombination is presently unclear.
Moreover, there is presently no reported evidence that DNA-
PK phosphorylates XRCC4 in vivo.
In the present study, we found two radiation-inducible
forms, i.e. p35 and p60, derived from XRCC4 using Western
blotting analysis of human leukemia MOLT-4 cells. We
showed that p35 was a caspase-cleaved fragment of
XRCC4, while p60 was produced through phosphorylation,
which required DNA-PKcs but not ATM.
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2. Materials and methods
2.1. Cells
A human T-cell leukemia cell line, MOLT-4, and a human mono-
cytic leukemia cell line, U937, were cultured in RPMI1640 medium
supplemented with 10% fetal calf serum (FCS). Human glioma cell
lines M059K and M059J [19] were purchased from the American Type
Culture Collection (Manassas, VA, USA) and cultured in Minimal
Essential Medium supplemented with 10% bovine calf serum. Simian
virus 40-transformed human ¢broblast cell lines from normal individ-
ual (LM217) and ataxia-telangiectasia patients (TAT5 and AT13LA,
obtained from Dr. A.M.R. Taylor and Dr. R. Gatti, respectively)
were cultured in a 1:1 mixture of Dulbecco’s modi¢ed Eagle’s medium
and Ham’s F12 medium supplemented with 10% FCS [10,20]. MOLT-
4 and U937 cells were recovered by centrifugation at 200Ug for 5 min,
whereas other cells were recovered by treatment with 0.25% trypsin
solution with 0.03% w/v EDTA disodium salt followed by centrifuga-
tion. Cell pellets were rinsed with phosphate-bu¡ered saline (8 g
NaCl, 0.2 g KCl, 1.15 g Na2HPO4 and 0.2 g KH2PO4 per l) and
stored at 370‡C until use.
2.2. Chemicals
Caspase inhibitors, Ac-YVAD-CHO and Ac-DEVD-CHO (Peptide
Institute, Minoh, Osaka, Japan), were dissolved at 10 mM in DMSO
(dimethylsulfoxide) and were stored at 340‡C. PI-3K inhibitor wort-
mannin (Sigma-Aldrich, St. Louis, MO, USA) was dissolved at 20 mM
in DMSO and stored at 340‡C [21].
2.3. Irradiation and heat treatment
Cells were X-ray irradiated using HF-350 (Shimadzu, Kyoto, Ja-
pan) at 2.8 Gy/min (operated at 200 kV, 20 mA with ¢lters of 0.5 mm
Cu and 1.0 mm Al) at room temperature unless otherwise indicated.
Caspase inhibitors were added to the medium immediately following
irradiation. Cells were heated by submerging the culture £asks in a
thermostatic water bath T-105 (Thomas, Tokyo, Japan) set at
44.0( þ 0.05)‡C [21].
2.4. Antibodies
Rabbit polyclonal antiserum against XRCC4 protein (AHP387)
was purchased from Serotec (Oxford, UK). Rabbit polyclonal anti-
body against DNA-PKcs (YM-CS.1) was newly raised in our labora-
tory. For antigen preparation, MOLT-4 cells were partly supplied as
pellets by Dr. Makoto Takeuchi and thr Fujisaki Institute of Hay-
ashibara Biochemical Laboratories (Okayama, Japan). DNA-PKcs
was puri¢ed from the nuclear extract of MOLT-4 cells through suc-
cessive column chromatography followed by sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) [22]. The gel pieces
containing DNA-PKcs were homogenized with Freund’s adjuvant
(Difco, Detroit, MI, USA) and injected subcutaneously into a female
rabbit. For a⁄nity puri¢cation, serum from the immunized rabbit was
applied onto polyvinylidenedi£uoride (PVDF) membrane (Millipore,
Bedford, MA, USA) with DNA-PKcs transblotted. The membrane
was rinsed with Tris-bu¡ered saline (20 mM Tris^HCl, pH 7.6,
0.9% NaCl) and the bound antibody was eluted with 0.2 M gly-
cine^HCl (pH 2.8). The eluate was neutralized by 2 M Tris^HCl
(pH 8.4), supplemented with 0.1% bovine serum albumin and 0.1%
sodium azide as preservatives and stored at 4‡C until use.
In Western blotting analysis, a single main band of 470 kDa was
detected either in the puri¢ed DNA-PK fraction or in the whole cell
lysate from MOLT-4 cells (data not shown). This band was also
detected in M059K cells, but not in M059J cells, which are de¢cient
in DNA-PKcs expression (data not shown). These results indicate a
high speci¢city of YM-CS.1 to DNA-PKcs.
2.5. SDS^PAGE and Western blotting analysis
Two million cells were suspended in 200 Wl of standard SDS^PAGE
sample bu¡er (62.5 mM Tris^HCl (pH 6.8), 2% sodium laurylsulfate,
10% glycerol, 2.5% L-mercaptoethanol, 0.01% bromophenolblue,
0.005% crystal violet) and lysed by heating at 95‡C for 5 min. After
centrifugation at 15 000Ug for 5 min, 5^40 Wl of supernatant was
electrophoresed through 5 or 10% polyacrylamide gel, respectively.
For analysis of XRCC4, proteins separated through a 10% gel were
transblotted onto PVDF membrane at 2 mA/cm2 for 1 h in transfer
bu¡er (10 mM Tris, 192 mM glycine, 10% v/v methanol), whereas for
analysis of DNA-PKcs, proteins separated through a 5% gel were
transblotted at 2 mA/cm2 for 1.5 h in transfer bu¡er containing
0.1% w/v SDS. The membrane was probed with YM-CS.1 (at 100-
fold dilution) or anti-XRCC4 antiserum (at 10 000-fold dilution) as
the primary antibody and peroxidase-conjugated antibody against
rabbit IgG (Dako, Glostrup, Denmark) as the secondary antibody
and was developed using an ECL-plus kit (Amersham-Pharmacia,
Buckinghamshire, UK) or Konica Immunostaining HRP-1000 kit
(Konica, Hachioji, Tokyo, Japan).
2.6. DNA analysis
The method for DNA preparation and DNA ladder formation
analysis has been previously described [23], with the exception that
the agarose gel concentration was 1.5% instead of 1.0%.
2.7. In vitro caspase treatment and analysis of XRCC4 and DNA-PKcs
Recombinant human caspase-3 and caspase-7 were purchased from
Medical and Biological Laboratories Co. (Nagoya, Japan). MOLT-4
cells were lysed in caspase bu¡er (20 mM PIPES, 100 mM NaCl, 10
mM DTT, 1 mM EDTA, 0.1% CHAPS, 10% sucrose, pH 7.2) [24]
with three freeze^thaw cycles, i.e. repeated freezing in liquid nitrogen
bath followed by thawing in water bath at 30‡C, and the lysate was
clari¢ed by centrifugation at 18 000Ug for 30 min at 4‡C. The reac-
tion mixture (16 Wl of ¢nal volume) contained 12 Wl MOLT-4 cell
lysate (protein concentration of 5 mg/ml) and either recombinant
caspase-3 (1.48 Wg, 13 U) or caspase-7 (1.26 Wg, 83 U). After incuba-
tion at 37‡C for 60 min, XRCC4 and DNA-PKcs were analyzed by
Western blotting, as described above.
2.8. In vitro phosphorylation
Crude cell lysate was prepared from MOLT-4 cells and was passed
through a DEAE Bio-Gel A column (BioRad, Hercules, CA, USA) as
described previously [25]. The £ow through was dialyzed overnight at
4‡C against 1.25U kinase bu¡er (25 mM HEPES^NaOH (pH 7.2),
187.5 mM KCl, 6.25 mM MgCl2, 10% glycerol, 1 mM dithiothreitol)
and centrifuged at 18 000Ug for 5 min. The phosphorylation reaction
mixture (10 Wl total volume) contained 8 Wl of the cell lysate (protein
concentration 5 mg/ml), 50 WM ATP and 10 ng/Wl of pBluescript
SKII(+) (Stratagene, La Jolla, CA, USA) with or without 100 Gy
X-irradiation and was incubated at 37‡C for 10 min. The reaction
was stopped by the addition of 10 Wl of 2USDS^PAGE sample bu¡er
and heating at 95‡C for 5 min and XRCC4 protein was analyzed by
Western blotting, as described above. Where indicated, cell lysate was
preincubated with 10 WM wortmannin or 1% v/v DMSO, as a control,
for 1.5 h on ice. For phosphatase treatment, 10 U of calf intestinal
phosphatase (Sigma-Aldrich) was added to the reaction mixture and
incubated at 37‡C for 20 min.
3. Results and discussion
3.1. p35: caspase-cleaved fragment of XRCC4 protein
The human T-cell leukemia cell line, MOLT-4, is highly
sensitive to X-irradiation and exhibits caspase-dependent rap-
id cell death with DNA fragmentation, indicating apoptosis
[26^28]. We recently reported that ceramide generation, which
in turn caused the phosphorylation of SAPK/JNK, was im-
portant for the radiation-induced apoptotic cell death of
MOLT-4 [29]. In SDS^PAGE and Western blotting analysis,
XRCC4 protein was mainly found as a 55 kDa band (p55) in
unirradiated MOLT-4 cells (Fig. 1, upper panels), as reported
previously [11^18]. However, we found an additional band of
35 kDa (p35), 4 h after 40 Gy (Fig. 4A) and 8 h after 10 Gy
X-irradiation (Fig. 1, upper left). The amount of p35 was
X-ray dose-dependent (Fig. 1, upper right). DNA-PKcs was
found mostly as a 470 kDa molecule in unirradiated MOLT-4
cells, but smaller forms of 240 and 160 kDa, which have been
reported as caspase-cleaved products [30^32], were found 4 h
after 40 Gy (data not shown) and 8 h after 10 Gy (Fig. 1,
lower left). Thus, the timing and dose-dependency of p35
appearance after irradiation was similar to the cleavage of
DNA-PKcs (present results), poly(ADP-ribose) polymerase
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(PARP) [28,29] and p42/SETL by caspase(s) ([26] and unpub-
lished data).
Additionally, p35 was also detectable concomitantly with
the smaller forms of DNA-PKcs in U937 cells 4 h after 40
Gy X-irradiation or 0.5 h after heating at 44‡C for 40 min
(Fig. 2, upper and middle panels). The internucleosomal DNA
fragmentation appeared 4 h after 40 Gy X-irradiation and 1
or 2 h after a 44‡C, 40 min treatment (Fig. 2, lower panels).
Thus, like the cleavage of DNA-PKcs by caspases, the timing
of p35 appearance was similar to or somewhat earlier than
DNA fragmentation, which is a hallmark of apoptosis.
We examined possible e¡ects of caspase inhibitors on p35
appearance. Ac-DEVD-CHO, an inhibitor of caspase-3/7-like
proteases, but not Ac-YVAD-CHO, an inhibitor of caspase-1/
4-like proteases, suppressed the appearance of p35 (Fig. 3A,
upper panel) and cleaved forms of DNA-PKcs (lower panel).
Additionally, p35 was produced in conjunction with 240 and
160 kDa forms of DNA-PKcs by treating MOLT-4 cell lysate
with recombinant caspase-3 or caspase-7 (Fig. 3B). These re-
sults suggest that p35 was derived from p55 by cleavage by
apoptosis-related proteases, like caspase-3/7.
Presently more than 10 caspase genes are found in the hu-
man genome and categorized into several subgroups with re-
gard to structure, function and substrate speci¢city [33,34].
Caspase-1/4-like proteases are thought to play important
roles, such as processing interleukin-1L, in the in£ammatory
response. Caspase-3/7-like proteases are converted from a la-
tent form into an active form through cleavage by caspase-8/
9-like proteases, disassembling the cytoskeleton, nuclear ma-
trix or chromosomal DNA, initiating the detachment of the
cell from its surrounding tissue structures and marking the
dying cells for engulfment by other cells such as macrophages.
These caspases have been reported to cleave a number of
DNA repair proteins, including DNA-PKcs ([30^32] and the
present study), PARP [35,36], the 140 kDa subunit of repli-
cation factor C [37] and Rad51 [38,39]. The present study
suggested that XRCC4 was also cleaved by a caspase-3/7-
like enzyme, producing a p35 fragment.
3.2. p60: phosphorylated form of XRCC4 requiring DNA-PK
but not ATM
In addition to p35, a band of 60 kDa (p60) was also de-
tected in 40 Gy X-irradiated MOLT-4 cells using anti-XRCC4
antibody (Fig. 4A). Although p60 was hardly detectable after
10 or 20 Gy irradiation, it increased with radiation dose (data
not shown). The appearance of p60 was much earlier than
that of p35: while p35 was detectable from 4 h after 40 Gy
X-irradiation, p60 was detected even 0.5 h after irradiation
(Fig. 4A,B). p60 was detectable until 4 h after irradiation but
was undetectable 8 h after irradiation (Fig. 4A). p60 was also
found after the incubation of crude lysate from unirradiated
MOLT-4 cells with ATP and X-irradiated plasmid DNA, but
not unirradiated plasmid DNA (Fig. 4C, lanes 1 and 2). p60
disappeared after phosphatase treatment, indicating that p60
is a phosphorylated form of XRCC4 (Fig. 4C, lanes 2 and 4).
Twenty WM wortmannin, an inhibitor of DNA-PK, ATM
and ATR as well as PI-3K [4,5,8^10], suppressed the appear-
ance of p60 in 40 Gy irradiated MOLT-4 cells (Fig. 4B).
Additionally, 10 WM wortmannin suppressed the appearance
of p60 in vitro, i.e. after incubation of MOLT-4 cell lysate
with ATP and irradiated plasmid DNA (Fig. 4D). These re-
sults suggest the possibility that p60 in X-irradiated MOLT-4
cells might be derived from p55 through phosphorylation by
Fig. 1. XRCC4 and DNA-PKcs in X-ray irradiated MOLT-4 cells.
MOLT-4 cells were irradiated with 2.5^40 Gy of X-ray and were re-
covered at various times after irradiation, as indicated. XRCC4
(upper panels) and DNA-PKcs (lower panels) were analyzed by
Western blotting.
Fig. 2. XRCC4, DNA-PKcs and DNA in X-irradiated or heated
U937 cells. U937 cells were either irradiated with 40 Gy of X-ray
(left panels) or heated at 44‡C for 40 min (right panels) and were
recovered at various times after treatment. XRCC4 (upper panels)
or DNA-PKcs (middle panels) was analyzed by Western blotting. In
lower panels, DNA was extracted from cells and analyzed by aga-
rose gel electrophoresis.
Fig. 3. A: E¡ect of caspase inhibitors on XRCC4 or DNA-PKcs
cleavage. MOLT-4 cells were irradiated with 10 Gy of X-ray and
treated with Ac-DEVD-CHO or Ac-YVAD-CHO at 10, 30 or
100 WM as a ¢nal concentration in the medium. Cells were recov-
ered 10 h after irradiation and XRCC4 (upper panel) and DNA-
PKcs (lower panel) were analyzed by Western blotting. B: In vitro
caspase treatment. The lysate from unirradiated MOLT-4 cells was
incubated with either recombinant human caspase-3 or caspase-7, as
indicated. After incubation at 37‡C for 60 min, XRCC4 or DNA-
PKcs was analyzed by Western blotting.
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DNA damage-responsive, wortmannin-sensitive kinases, like
DNA-PK, ATM or ATR [4,5,8^10]. On the other hand, 20
WM wortmannin did not suppress the appearance of p35 in 40
Gy X-irradiated MOLT-4 cells (Fig. 4B), suggesting that p60
production was not likely a prerequisite for cleavage produc-
ing p35.
p60 was not found in DNA-PKcs-de¢cient M059J cells but
was found in control M059K cells 0.5 h after 100 Gy X-irra-
diation (Fig. 5A). However, p60 was detectable 0.5 h after 100
Gy X-irradiation in two ¢broblast cell lines from an ataxia-
telangiectasia patient, i.e. TAT5 and AT13LA, as well as in
normal human ¢broblasts, LM217 (Fig. 5B). These results
suggest that DNA-PKcs, but not ATM, is necessary for the
radiation-induced phosphorylation of XRCC4.
In in vitro studies, DNA-PK has been reported to phos-
phorylate recombinant XRCC4 and to change the association
of XRCC4 with DNA [11,15,18]. The present study clearly
demonstrated for the ¢rst time that radiation could induce
phosphorylation of XRCC4 in vivo, requiring DNA-PKcs
but not ATM, although these results could not entirely ex-
clude a possibility of indirect phosphorylation through other
kinase(s).
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